with one observation
Alembic Pharmaceuticals announced that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with one observation. The inspection was carried out from 16 September, 2019 to 20 September, 2019.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
